In the type 1 diabetes model, streptozotocin (STZ) is a widely used diabetogenic agent (14), Previous studies have shown that HMGB1 is activated and the expression is increased in STZ-induced diabetic mice (15, 16). This evidence concerns the gene HMGB1 and type 1 diabetes mellitus.